Search Results
Sep 29, 2025, 17:46 ET Novo Nordisk resubmits Awiqli® to the FDA with potential to be the first once-weekly basal insulin treatment for adults with type 2 diabetes
option for people living with type 2 diabetes that, if approved, could reduce their yearly basal insulin injections from 365 to 52," said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical and Regulatory Affairs at Novo Nordisk. "It is critical that we continue to build upon our 100-year
More news about: Novo Nordisk
Sep 29, 2025, 11:03 ET LEADING MATERNAL HEALTH PHYSICIAN-SCIENTIST ANDREEA CREANGA, MD, PHD, NAMED CHAIR OF THE DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH AT THE UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Dean Mark T. Gladwin, MD, announced today that Andreea Creanga, MD, PhD, a distinguished and internationally recognized leader in maternal and perinatal health, has been appointed the new Chair of the
More news about: University of Maryland Medical Center
Sep 29, 2025, 09:11 ET Pacific Northwest Research Institute Announces Listing of Building at 720 Broadway in Seattle
always adapted to the evolving landscape of biomedical science, even in times when research funding has been especially challenging," said Mark Rieder, PhD, Chief Operating Officer of PNRI. "This decision positions us to pursue new opportunities for collaboration and growth, while ensuring that our discovery
More news about: Pacific Northwest Research Institute
Sep 29, 2025, 09:10 ET Qaelon Medical Welcomes Dr. Marylise Boutros to Scientific Advisory Board
Joel Dunning, MD, MBBS, PhD and thoracic surgeon at James Cook University Hospital in the UK. "We're honored to welcome Dr. Boutros to our Scientific Advisory
More news about: Qaelon Medical
Sep 29, 2025, 08:30 ET Solutions For Recombinant Protein Expression, Upcoming Webinar Hosted by Xtalks
design, host selection and process optimization. Join Dominic Esposito, PhD, Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research; Mark Welch, PhD, VP, Research & Development,
More news about: Xtalks
Sep 29, 2025, 08:05 ET Novo Nordisk resubmits Awiqli® to the FDA with potential to be the first once-weekly basal insulin treatment for adults with type 2 diabetes
option for people living with type 2 diabetes that, if approved, could reduce their yearly basal insulin injections from 365 to 52," said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical and Regulatory Affairs at Novo Nordisk. "It is critical that we continue to build upon our 100-year
More news about: Novo Nordisk
Sep 29, 2025, 08:00 ET EY Pulse of the MedTech Industry Report 2025: MedTech vital signs are robust, reigniting growth and expanding markets in a disrupted healthcare landscape
operating models will be best positioned to deliver long-term growth and shareholder value," says EY Americas Life Sciences Sector Leader Arda Ural, PhD. The Pulse of the MedTech Industry report captures the current state of the sector, covering financial performance, spending trends,
More news about: EY
Sep 29, 2025, 08:00 ET U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor
deserves to feel comfortable in their own skin and to be active without the limitations of joint pain, stiffness and swelling," said Brandee Pappalardo, PhD, MPH, Vice President, Medical Affairs, Dermatology & Rheumatology, Johnson & Johnson Innovative Medicine. "The approval of the first and only
More news about: Johnson & Johnson
Sep 29, 2025, 07:00 ET CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
[email protected] Investor Relations Contact:Aman Patel, CFA & Adanna G. Alexander, PhDICR Healthcare [email protected]
More news about: Cytosorbents Corp
Sep 26, 2025, 09:30 ET webAI Expands Work Within Public Sector with New Executive Hires
the Office of Strategic Capital, drove research for AFWERX, the U.S. Air Force's commercial innovation unit, and worked at Accenture. Eric earned a PhD from Stanford University, with a focus on how mission-driven startups compete across the public and private sectors.
More news about: webAI
Sep 26, 2025, 09:27 ET ASCP Launches Advanced Analytics and Benchmarking Platform to Transform Laboratory Performance
do more with fewer resources, while maintaining the highest standards of accuracy and compliance," says Sachin Gupta, PhD, MBA, MLS(ASCPi)MBi, LSSBB, CPHQ, Scientific Director of the Center for Quality and Patient Safety of ASCP. "This platform gives
More news about: American Society of Clinical Pathology
Sep 26, 2025, 09:00 ET Meet INSEAD AI50 - An alumni-led recognition of global AI builders
in our Master in Management, MBA, Global Executive MBA, Specialised Master's degrees (Executive Master in Finance and Executive Master in Change) and PhD programmes. In addition, more than 18,000 executives participate in INSEAD Executive Education programmes each year. INSEAD continues to conduct
More news about: INSEAD
Sep 26, 2025, 08:30 ET Alexandria Real Estate Equities, Inc. Strategically Partners With Lilly on Newest Lilly Gateway Labs at the One Alexandria Square Megacampus in San Diego's Torrey Pines to Accelerate the Development of Life-Changing Medicines
expand the transformative Gateway Labs platform in San Diego," said Hallie E. Kuhn, PhD, senior vice president and co-lead of life science and capital markets at Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments. "Our
More news about: Alexandria Real Estate Equities, Inc.
Sep 25, 2025, 14:14 ET Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO NEW YORK, Sept.
More news about: Axon Therapies
Sep 25, 2025, 14:05 ET Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO NEW YORK, Sept.
More news about: Axon Therapies
Sep 25, 2025, 11:07 ET While It May Go Unnoticed, Loss of Smell May Linger for Years After COVID-19
Horwitz, Jacqueline Becker, PhD at Icahn School of Medicine at Mount Sinai in New York is co-lead author. Hassan Ashktorab, PhD, at Howard University in
More news about: NYU Grossman School of Medicine and NYU Langone Health
Sep 25, 2025, 10:53 ET Breaking Barriers in STEM: Neda Nobari's Visionary Philanthropy Launches Maryam Mirzakhani Presidential Scholarships at San Francisco State University
only the space to excel academically, but also the support to grow as catalysts for progress," said Mia S. Reisweber, PhD, Associate Dean of Students, Division of Student Life, Student Affairs at SFSU. For Nobari, a proud SFSU computer science graduate and lifelong
More news about: MOZAIK Philanthropy
Sep 25, 2025, 09:35 ET Retirement Confidence High Among US Employees, Yet Many Make Basic Financial Mistakes
"Even financially knowledgeable investors often make emotional decisions during market volatility," said Eric Ludwig, PhD, CFP®, Director of the Center for Retirement Income at The American College of Financial Services. "The solution isn't just more education, but plan
More news about: Nationwide
Sep 25, 2025, 09:30 ET Israel Cancer Research Fund Partners with The Mark Foundation for Cancer Research to Support Lung Cancer Project Grant at Weizmann Institute of Science
Research (MFCR) have partnered on a new award, The ICRF-Mark Foundation Collaborative Project Grant, given to Yosef Yarden, PhD, of the Weizmann Institute of Science in Israel. Professor Yarden was awarded $180,000
More news about: Israel Cancer Research Fund
Sep 25, 2025, 09:03 ET Radicle Science Continues to Expand Executive Bench with Industry Leaders to Accelerate Growth
panel discussion on AI accelerating supplement innovation; and Radicle's SVP, Scientific Affairs, Dr. Susan Hewlings, PhD, RD, will speak on the state of sports and active nutrition. About Radicle Science Radicle Science is a health tech trailblazer
More news about: Radicle Science
Sep 25, 2025, 09:00 ET Flat Medical Establishes Clinical Advisory Board for Pain Interventions, Names Dr. Krishnan Chakravarthy as Chairman
Clinical Advisory Board for Chronic Pain Interventions and the appointment of Dr. Krishnan Chakravarthy, MD, PhD, as its inaugural Chairman. This strategic initiative positions Flat Medical to accelerate innovation in chronic pain management technologies and expand
More news about: Flat Medical
Sep 25, 2025, 09:00 ET Challenge Your Score: Workera Debuts Score Appeal to Align Its AI Agent with Expert Human Judgment
reshaping how organizations measure skills, but adoption stalls if the results feel like a black box," said Taylor Sullivan, PhD, Head of Product at Workera. "With Score Appeal, Workera is bringing a human into the loop to build trust so both individuals and leaders can take action
More news about: Workera.ai
Sep 25, 2025, 08:01 ET Breakthrough T1D, Lupus Research Alliance, and National Multiple Sclerosis Society Award Recipients of First Common Mechanisms of Autoimmunity Insight Award
opportunity to continue our collaboration on research that may provide key insights that benefit everyone," Joshua Vieth, PhD, Senior Director of Research at Breakthrough T1D, said. "By working together to advance our collective understanding of autoimmunity, we can reduce gaps
More news about: Lupus Research Alliance
Sep 25, 2025, 07:41 ET Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
firm. The team is led by Srinivas Akkaraju, who has over twenty-seven years of industry experience and has an MD and a PhD in Immunology from Stanford University. Contact: Respira Therapeutics, Inc.John
More news about: Respira Therapeutics, Inc.
Sep 25, 2025, 07:00 ET Daymark Health Raises $20M in Series A Funding to Scale Tech-Enabled Cancer Care Platform to Thousands of Patients
personalized care for patients with cancer, while improving outcomes and reducing avoidable costs," said Aman Mahajan, MD, PhD, Partner at Healthier Capital. "Daymark is delivering a transformational model of personalized, high-quality, value-based cancer care." "Daymark
More news about: Daymark Health